Literature DB >> 18215199

Endoscopic haemostasis of staple-line haemorrhage following colorectal resection.

A H Malik1, J E East, G N Buchanan, R H Kennedy.   

Abstract

OBJECTIVE: Bleeding from stapled colonic stapled anastomoses is rare, but occasionally may be severe enough to require re-operation, with associated morbidity. Endoscopic therapy is a potential alternative.
METHOD: We examined a large 15-year prospective series of patients who had undergone colorectal resection with stapled anastomosis. We reviewed the management of cases where severe postoperative rectal bleeding had occurred.
RESULTS: In six of 777 (0.8%) patients, bleeding occurred that was severe enough to require intervention. In the first three cases, conventional re-operation was performed. In the latter three cases, endoscopic therapy (adrenaline injection, diathermy or endoscopic clipping) was used to control the bleeding. No complications occurred as a result of endoscopic therapy, either patient or anastomosis related.
CONCLUSION: Endoscopic management using standard endoscopic techniques appears safe and effective for haemostasis in colorectal stapled anastomotic bleeding. Endoscopic therapy should probably be attempted before re-operation is considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18215199     DOI: 10.1111/j.1463-1318.2007.01459.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  15 in total

1.  Endoscopic treatment for lower gastrointestinal bleeding.

Authors:  Charles B Whitlow
Journal:  Clin Colon Rectal Surg       Date:  2010-02

2.  Management of postoperative bleeding after laparoscopic left colectomy.

Authors:  Romain Besson; Christos Christidis; Christine Denet; Laurence Bruyns; Hugues Levard; Brice Gayet; David Fuks; Thierry Perniceni
Journal:  Int J Colorectal Dis       Date:  2016-06-06       Impact factor: 2.571

Review 3.  [Perioperative complications of the lower gastrointestinal tract : Prevention, recognition and treatment].

Authors:  Y Kulu; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2015-04       Impact factor: 0.955

4.  Hemospray treatment for bleeding intestinal anastomoses in the early postoperative period: a novel non-operative approach.

Authors:  C Gubler; J M Metzler; M Turina
Journal:  Tech Coloproctol       Date:  2016-05-12       Impact factor: 3.781

Review 5.  Colorectal Surgery in Critically Unwell Patients: A Multidisciplinary Approach.

Authors:  Ashwin Subramaniam; Robert Wengritzky; Stewart Skinner; Kiran Shekar
Journal:  Clin Colon Rectal Surg       Date:  2022-02-09

6.  Emergency colectomies in the NOAC era: a nationwide analysis demonstrating increased complications.

Authors:  Jeongyoon Moon; Maryam AlFarsi; Daniel Marinescu; Mohammed AlQahtani; Allison Pang; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  Surg Endosc       Date:  2022-09-26       Impact factor: 3.453

7.  Staple line haemorrhage following laparoscopic left-sided colorectal resections may be more common when the inferior mesenteric artery is preserved.

Authors:  T Y Linn; B J Moran; T D Cecil
Journal:  Tech Coloproctol       Date:  2008-11-18       Impact factor: 3.781

8.  Impact of perioperative aspirin continuation on bleeding complications in laparoscopic colorectal cancer surgery: a propensity score-matched analysis.

Authors:  Ryo Takahashi; Takahisa Fujikawa
Journal:  Surg Endosc       Date:  2020-05-06       Impact factor: 4.584

9.  Transarterial embolization for massive gastrointestinal hemorrhage following abdominal surgery.

Authors:  Chun-Gao Zhou; Hai-Bin Shi; Sheng Liu; Zheng-Qiang Yang; Lin-Bo Zhao; Jin-Guo Xia; Wei-Zhong Zhou; Lin-Sun Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Gastrointestinal Bleed After Total Pancreatectomy With Islet Autotransplant.

Authors:  Alexandria J Robbins; Elizabeth Lusczek; Melena D Bellin; Fatima S Alwan; James S Hodges; Scott A Chapman; Gregory J Beilman
Journal:  Pancreas       Date:  2021-07-01       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.